Lantheus Holdings reports sale of 78,145 Perspective Therapeutics shares worth $245,641
LNTH•Lantheus reports sale of Perspective Therapeutics shares
- Lantheus Holdings sold 78,145 Perspective Therapeutics common shares on Aug. 31.
- Shares sold at a weighted average price of $3.14.
- Lantheus Holdings reported 11,599,194 shares beneficially owned following the sale.
